CClinicalTrials.gg
Not yet recruitingNCT07613268Updated May 29, 2026

Exploratory Trial of the "HiDongDong" Language Rehabilitation App for Articulation Delay.

An interventional study of HiDongDong Intervention and Standard Care / Speech Therapist Intervention in Speech Sound Disorder, Language Development Disorders and Phonological Disorder, sponsored by Seoul National University Bundang Hospital. Not yet recruiting at 1 site in South Korea. Open to participants aged 2 Years to 13 Years. Per ClinicalTrials.gov, last updated 2026-05-29.

Sponsored by Seoul National University Bundang Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
2 Years to 13 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of the AI-based application "HiDongDong" in improving articulation development in children aged 2 to under 14 years with suspected articulation delays. The program provides individualized language training based on a personalized assessment of vulnerable speech sounds. This trial aims to determine whether the digital therapeutic solution can enhance articulation skills and inform future strategies for language rehabilitation in children.

Read the detailed description

This exploratory randomized controlled trial (RCT) evaluates the effectiveness of the AI-based application "HiDongDong" in improving articulation in children aged 2 to under 14 years with suspected articulation delays.

1. Study Methods

  1. Screening and Enrollment Children suspected of articulation developmental delay will be assessed for eligibility according to predefined inclusion and exclusion criteria. Eligible participants will be enrolled, randomized, and scheduled for study visits.
  2. Visit 1 - Baseline Assessment

    At the first visit, a blinded assessor will collect demographic data (child's age, sex, and underlying medical conditions) and conduct a single baseline assessment, including the following:

    • Language assessments: U-TAP (Urimal Test of Articulation and Phonology)

      • SELSI (Sequenced Language Scale for Infants) or PRES (Preschool Receptive- Expressive Language Scale)
    • Functional independence: WeeFIM (Functional Independence Measure for Children)
    • Caregiver emotional status: Satisfaction (5-point Likert scale), depression (BDI; Beck Depression Inventory), anxiety (BAI; Beck Anxiety Inventory)
    • Clinician satisfaction: 5-point Likert scale
  3. Post-Assessment Procedures Following baseline assessment, the control group will be discharged and return home. For the intervention group, a personalized language training program will be generated based on the results of the HiDongDong assessment.
  4. Training and Orientation Participants in the intervention group will receive instruction on how to use the HiDongDong language training program, along with guidance on the study procedures.
  5. Intervention Period The intervention group will complete the HiDongDong language training program at home under caregiver supervision for 4 weeks, 5 sessions per week, 20 minutes per session. Adherence will be monitored throughout the intervention period. The control group will receive language training provided by a speech-language pathologist.
  6. Visit 2 - Post-Intervention Assessment and Study Completion Four weeks after the intervention, both the control and intervention groups will undergo a single post-intervention assessment conducted by a blinded assessor. Upon completion of the assessment, follow-up will be concluded.

2. Comparator and Randomization Participants will be randomized by an independent statistician affiliated with the Medical Research Collaborating Center of the Biomedical Research Institute at Seoul National University Bundang Hospital (SNUBH), using SAS version 9.4.

Assessor blinding will be applied. A blinded assessor (e.g., a hospital-based speech-language pathologist) will conduct all assessments without knowledge of each participant's group allocation, in an independent time and setting.

The sole difference between the two groups is the provider of the intervention:

  • Control group: Language training delivered by a speech-language pathologist
  • Intervention group: Language training delivered via the HiDongDong application (investigational medical device)

Participants will return after 4 weeks for post-intervention assessment by a blinded assessor, after which follow-up will be concluded.

To prevent interim analysis, assessment results will not be disclosed to any study personnel until the dataset is complete.

02

Conditions studied

  • Speech Sound Disorder
  • Language Development Disorders
  • Phonological Disorder

Keywords

  • Phonological Delay
  • AI-based Therapy
  • Digital Therapeutic
  • Pediatric Speech Development
  • Application-Based Language Rehabilitation
  • Articulation Delay
  • Speech Sound Disorder
  • Language Development Disorders
03

Who can participate

Ages eligible
2 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Children aged 2 years to under 14 years
  2. Persistent difficulties in speech sound production, or reduced speech intelligibility that interferes with communicative participation, resulting in limitations in social participation, academic performance, or daily activities
  3. Articulation developmental delay suspected based on U-TAP results, with articulation performance more than 1 standard deviation below the mean for the same age group (-1SD)
  4. Sufficient cognitive ability to follow simple instructions via a mobile device (tablet)
  5. For children under 7 years of age: a caregiver who has received sufficient explanation of the study purpose and procedures and has voluntarily provided written informed consent
  6. For children aged 7 years or older: voluntary assent from the child after sufficient explanation of the study purpose and procedures by the investigator,

in addition to written informed consent from the caregiver

Exclusion criteria

Exclusion Criteria:

  1. Caregiver or child does not consent to study participation, or withdraws consent during the study
  2. U-TAP results indicate articulation development within the normal range, with no suspicion of articulation developmental delay
  3. Difficulty understanding simple instructions or participating in assessments and training due to moderate or severe cognitive impairment, attention deficit, autism spectrum disorder, or similar conditions
  4. Significantly limited speech production due to neuromuscular or anatomical causes, including severe visual impairment or visual field deficits, hearing impairment, cleft palate structural abnormalities, or severe oral/facial muscle dysfunction, resulting in difficulty with articulation
  5. Inability to continue study participation due to acute illness or other conditions that may affect assessment or training during the study period, or unwillingness of the caregiver or child to continue participation
  6. Determination by the principal investigator that study participation may pose a risk to the safety or well-being of the child

Any one of the above exclusion criteria is sufficient for exclusion.

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    HiDongDong Intervention

    Participants will receive a 4-week individualized articulation training program delivered via the AI-based HiDongDong application. Training will be conducted at home under caregiver monitoring, 5 sessions per week, 20 minutes per session. Adherence and engagement will be monitored. Pre- and post-intervention assessments will measure articulation accuracy, speech intelligibility, and overall language performance.

    Device: HiDongDong Intervention

  • Active comparator
    Standard Care / Speech Therapist Intervention

    Participants will receive standard articulation training conducted by a certified speech-language therapist. Outcome assessments will be conducted at the same time points as the experimental group for comparison.

    Behavioral: Standard Care / Speech Therapist Intervention

Interventions

  • DeviceHiDongDong Intervention

    Participants will receive a 4-week individualized articulation training program delivered via the AI-based HiDongDong application. Training is conducted at home under caregiver monitoring, 5 sessions per week, 20 minutes per session. Exercises are tailored to each child's articulation needs based on baseline assessment using U-TAP and the study-specific word list. Adherence and engagement will be monitored.

  • BehavioralStandard Care / Speech Therapist Intervention

    Participants will receive standard articulation training conducted by a certified speech-language therapist. Outcome assessments will be conducted at the same time points as the experimental group for comparison.

05

What researchers measure

Primary outcomes

  1. Consonant accuracy (%) and vowel accuracy (%) assessed via U-TAP

    Korean Articulation and Phonology Assessment (U-TAP). Changes in articulation accuracy will be evaluated following the 4-week HiDongDong intervention compared to the control group. A blinded speech-language therapist will present picture stimuli, and children's consonant and vowel production will be analyzed at word and sentence levels to identify misarticulations and error patterns.

    Time frame: Baseline and post-intervention (4 weeks)

Other outcomes

  1. Receptive language score measured by SELSI

    Receptive language ability is assessed using the Sequenced Language Scale for Infants (SELSI). Higher scores indicate better receptive language comprehension ability.

    Time frame: Baseline and post-intervention (4 weeks)

  2. Receptive language score measured by PRES

    Receptive language ability is assessed using the Preschool Receptive-Expressive Language Scale (PRES). Higher scores indicate better receptive language comprehension ability.

    Time frame: Baseline and post-intervention (4 weeks)

  3. Expressive language score measured by SELSI

    Expressive language ability is assessed using the Sequenced Language Scale for Infants (SELSI). Higher scores indicate better expressive language ability.

    Time frame: Baseline and post-intervention (4 weeks)

  4. Expressive language score measured by PRES

    Expressive language ability is assessed using the Preschool Receptive-Expressive Language Scale (PRES). Higher scores indicate better expressive language ability.

    Time frame: Baseline and post-intervention (4 weeks)

  5. Functional Independence (WeeFIM)

    Total score (18-126 points) across 6 domains and 18 items assessing functional independence in daily living activities; higher scores indicate greater independence.

    Time frame: Baseline and post-intervention (4 weeks)

  6. Caregiver Satisfaction

    Caregiver satisfaction assessed using a 5-point Likert scale; higher scores indicate greater satisfaction.

    Time frame: Baseline and post-intervention( 4 weeks)

  7. Caregiver Depression(Beck Depression Inventory)

    Caregiver depression assessed using the Beck Depression Inventory (BDI); total score ranges from 0 to 63, with higher scores indicating more severe depressive symptoms.

    Time frame: Baseline and post-intervention (4 weeks)

  8. Caregiver Anxiety(Beck Anxiety Inventory)

    Caregiver anxiety assessed using the Beck Anxiety Inventory (BAI); total score ranges from 0 to 63, with higher scores indicating more severe anxiety symptoms.

    Time frame: Baseline and post-intervention( 4 weeks)

  9. Clinician Satisfaction

    Clinician satisfaction assessed using a 5-point Likert scale (1-5); higher scores indicate greater satisfaction.

    Time frame: Baseline and post-intervention( 4 weeks)

06

Study locations

1 site
  • Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do 13620, South Korea
07

References and documents

Individual participant data

Plan to share: No — Individual participant data collected during the study will not be shared, in order to protect the privacy of pediatric participants and in accordance with institutional policy.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07613268
Lead sponsor
Seoul National University Bundang Hospital
Collaborators
National IT Industry Promotion Agency, South Korea
Responsible party
JeeHyun Suh (Professor, Seoul National University Bundang Hospital) — Principal investigator
First posted
May 29, 2026
Start date
May 2026 (estimated)
Primary completion
Jul 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
May 29, 2026

Study contacts

SEJIN KWON, BHS
Contact
RQ300@snubh.org
+82 10-2939-7143

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion